HRP20020558A2 - Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof - Google Patents

Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof Download PDF

Info

Publication number
HRP20020558A2
HRP20020558A2 HR20020558A HRP20020558A HRP20020558A2 HR P20020558 A2 HRP20020558 A2 HR P20020558A2 HR 20020558 A HR20020558 A HR 20020558A HR P20020558 A HRP20020558 A HR P20020558A HR P20020558 A2 HRP20020558 A2 HR P20020558A2
Authority
HR
Croatia
Prior art keywords
amino
oxo
pyridazino
octahydro
dioxo
Prior art date
Application number
HR20020558A
Other languages
English (en)
Croatian (hr)
Inventor
Neerja Bhatnagar
Jacques Mauger
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020558(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP20020558A2 publication Critical patent/HRP20020558A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20020558A 1999-12-28 2000-12-21 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof HRP20020558A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9916567A FR2802927B1 (fr) 1999-12-28 1999-12-28 Nouveaux derives de diazepine carboxamide, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et leur nouvelle utilisation
PCT/FR2000/003622 WO2001047930A1 (fr) 1999-12-28 2000-12-21 Derives de diazepine carboxamide, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et leur utilisation

Publications (1)

Publication Number Publication Date
HRP20020558A2 true HRP20020558A2 (en) 2004-02-29

Family

ID=9553901

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020558A HRP20020558A2 (en) 1999-12-28 2000-12-21 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof

Country Status (26)

Country Link
EP (1) EP1246824B1 (de)
JP (1) JP2003519152A (de)
KR (1) KR20020062772A (de)
AT (1) ATE268775T1 (de)
AU (1) AU780522B2 (de)
BR (1) BR0016845A (de)
CA (1) CA2395275A1 (de)
DE (1) DE60011473T2 (de)
DK (1) DK1246824T3 (de)
EA (1) EA005288B1 (de)
EE (1) EE200200362A (de)
ES (1) ES2218275T3 (de)
FR (1) FR2802927B1 (de)
HR (1) HRP20020558A2 (de)
HU (1) HUP0203921A3 (de)
IL (1) IL150419A0 (de)
MX (1) MXPA02006413A (de)
NO (1) NO20023107L (de)
NZ (1) NZ519884A (de)
PL (1) PL355950A1 (de)
PT (1) PT1246824E (de)
SI (1) SI1246824T1 (de)
SK (1) SK9092002A3 (de)
WO (1) WO2001047930A1 (de)
YU (1) YU47502A (de)
ZA (1) ZA200205221B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220115062A (ko) 2021-02-09 2022-08-17 (주)오스티오뉴로젠 크로몬 구조의 화합물을 포함하는 골다공증의 예방 및 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
PL355950A1 (en) 2004-05-31
KR20020062772A (ko) 2002-07-29
ATE268775T1 (de) 2004-06-15
HUP0203921A2 (hu) 2003-03-28
NO20023107D0 (no) 2002-06-27
EA005288B1 (ru) 2004-12-30
EA200200721A1 (ru) 2002-12-26
SK9092002A3 (en) 2003-04-01
HUP0203921A3 (en) 2005-01-28
FR2802927A1 (fr) 2001-06-29
ZA200205221B (en) 2003-09-04
DE60011473D1 (de) 2004-07-15
PT1246824E (pt) 2004-10-29
BR0016845A (pt) 2002-10-15
YU47502A (sh) 2005-03-15
FR2802927B1 (fr) 2002-03-01
AU780522B2 (en) 2005-03-24
WO2001047930A1 (fr) 2001-07-05
DE60011473T2 (de) 2005-06-30
NZ519884A (en) 2005-03-24
EP1246824A1 (de) 2002-10-09
IL150419A0 (en) 2002-12-01
NO20023107L (no) 2002-08-27
EE200200362A (et) 2003-08-15
AU2688801A (en) 2001-07-09
EP1246824B1 (de) 2004-06-09
CA2395275A1 (fr) 2001-07-05
ES2218275T3 (es) 2004-11-16
SI1246824T1 (en) 2004-10-31
MXPA02006413A (es) 2002-11-29
JP2003519152A (ja) 2003-06-17
DK1246824T3 (da) 2004-10-18

Similar Documents

Publication Publication Date Title
US11639353B2 (en) Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
EP3953330B1 (de) Nitrilhaltige verbindungen als antiviral-agenten zur behandlung von einer coronavirus infektion
AU2026202278A1 (en) Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
ES2605848T3 (es) Derivados de pirrolo-pirazol sustituidos como inhibidores de cinasa
ES2328405T3 (es) Piperazina sustituida por 2-aminocarbonil o compuestos diaza-ciclicos como moduladores del inhibidor de la proteina de la apoptosis (iap).
CN111606970B (zh) 一种1，5-二氮杂双环[5,3,0]十烷酮氨基酸衍生物及其制备方法和应用
ES2218275T3 (es) Derivados de diazepin-carboxamida, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y su utilizacion.
JP2001139534A (ja) バリン誘導体およびその用途
US20030100550A1 (en) Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
US7223758B2 (en) Pyridazine derivative, pharmaceutical composition thereof, its pharmaceutical use, and process for its preparation
US7034022B2 (en) Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation
JP2006503810A (ja) 新規なアシルヒドラジノチオフェン誘導体、それらの製法、それらの医薬品としての使用、医薬組成物および新規な使用。
RU2781452C2 (ru) Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью e3 убиквитин лигазы
MXPA04010747A (es) Nuevos derivados hidrazida o hidrazona del acido hexahidro-piridazin-3-carboxilico, quimiotecas que los contienen, su utilizacion como medicamentos, composiciones farmaceuticas que los contienen y sus procedimientos de preparacion.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn